IPSC — CENTURY THERAPEUTICS INC

Ownership history in Qube Research & Technologies Ltd  ·  6 quarters on record

This page tracks every 13F SEC filing in which Qube Research & Technologies Ltd reported a position in CENTURY THERAPEUTICS INC (IPSC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2021 Q2)
Avg. % of fund
0.0%
First filed
2021 Q2
Last filed
2025 Q3
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 17,501 -50,236 -74.2% 0.00% $9K $0.50
2025 Q2 ADDED 67,737 +67,403 +20180.5% 0.00% $38K $0.56
2024 Q1 ADDED 334 +326 +4075.0% 0.00% $1K $4.18
2023 Q4 REDUCED 8 -10,624 -99.9% 0.00% $27 $3.32
2022 Q4 REDUCED 10,632 -9,347 -46.8% 0.00% $55K $5.13
2021 Q2 INITIATED 19,979 — — 0.01% $586K $29.34
% of Fund (quarterly)    IPSC price (monthly, adj. close)

Other funds also holding IPSC

As of 2025 Q4 — sorted by position size

Syncona Portfolio Ltd 3Y 3.52% DAFNA Capital Management LLC 3Y 7Y 0.65% SUPERSTRING CAPITAL MANAGEMENT LP 0.25% Casdin Capital, LLC 3Y 7Y 0.08% Parametrica Management Ltd 3Y 7Y 0.04% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.03% HARBOURVEST PARTNERS LLC 3Y 7Y 0.02% Scientech Research LLC 0.01% Point72 Asset Management, L.P. 3Y 7Y 0.01% ADAGE CAPITAL PARTNERS GP, L.L.C. 3Y 7Y 0.0%
← Back to Qube Research & Technologies Ltd Holdings